Dual Expression Profile of Type VI Secretion System Immunity Genes Protects Pandemic Vibrio cholerae

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-18

  Miyata, Sarah T ^a   Unterweger, Daniel ^a   Rudko, Sydney P ^a   Pukatzki, Stefan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BACTERIAL PROTEIN; TRANSCRIPTOME;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOINFORMATICS; CELL MEMBRANE PERMEABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNITY; MEMBRANE POTENTIAL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; TSIV1 GENE; TSIV2 GENE; TSIV3 GENE; TYPE VI SECRETION SYSTEM; VIBRIO CHOLERAE; VIRUS VIRULENCE; WESTERN BLOTTING; ANTIBIOSIS; BACTERIAL SECRETION SYSTEM; DICTYOSTELIUM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PATHOGENICITY; TRANSGENIC ORGANISM; VIRULENCE;

ANTIBIOSIS; BACTERIAL PROTEINS; BACTERIAL SECRETION SYSTEMS; DICTYOSTELIUM; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; ORGANISMS, GENETICALLY MODIFIED; TRANSCRIPTOME; VIBRIO CHOLERAE; VIRULENCE;

EID: 84892168352     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003752     Document Type: Article

References (82)

1. Williams SG, Varcoe LT, Attridge SR, Manning PA, (1996) Vibrio cholerae Hcp, a secreted protein coregulated with HlyA. Infect Immun 64: 283-289.
2. Ballister ER, Lai AH, Zuckermann RN, Cheng Y, Mougous JD, (2008) In vitro self-assembly of tailorable nanotubes from a simple protein building block. Proc Natl Acad Sci U S A 105: 3733-3738.
3. Silverman JM, Agnello DM, Zheng H, Andrews BT, Li M, et al. (2013) Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates. Mol Cell 51: 584-593.
4. Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ, (2007) Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A 104: 15508-15513.
5. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, et al. (2006) Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A 103: 1528-1533.
6. Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, et al. (2009) Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin. Proc Natl Acad Sci U S A 106: 4154-4159.
7. Basler M, Mekalanos JJ, (2012) Type 6 secretion dynamics within and between bacterial cells. Science 337: 815.
8. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ, (2012) Type VI secretion requires a dynamic contractile phage tail-like structure. Nature 483: 182-186.
9. Bonemann G, Pietrosiuk A, Diemand A, Zentgraf H, Mogk A, (2009) Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion. EMBO J 28: 315-325.
10. Ma AT, McAuley S, Pukatzki S, Mekalanos JJ, (2009) Translocation of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by host cells. Cell Host Microbe 5: 234-243.
11. Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ, (2013) Identification of T6SS-dependent effector and immunity proteins by Tn-seq in Vibrio cholerae. Proc Natl Acad Sci U S A 110: 2623-2628.
12. Brooks TM, Unterweger D, Bachmann V, Kostiuk B, Pukatzki S, (2013) Lytic activity of the Vibrio cholerae type VI secretion toxin VgrG-3 is inhibited by the antitoxin TsaB. J Biol Chem 288: 7618-7625.
13. Ma LS, Lin JS, Lai EM, (2009) An IcmF family protein, ImpLM, is an integral inner membrane protein interacting with ImpKL, and its walker a motif is required for type VI secretion system-mediated Hcp secretion in Agrobacterium tumefaciens. J Bacteriol 191: 4316-4329.
14. Shneider MM, Buth SA, Ho BT, Basler M, Mekalanos JJ, et al. (2013) PAAR-repeat proteins sharpen and diversify the type VI secretion system spike. Nature 500: 350-353.
15. Zinnaka Y, Carpenter CC Jr, (1972) An enterotoxin produced by noncholera Vibrios. Johns Hopkins Med J 131: 403-411.
16. MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S, (2010) The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci U S A 107: 19520-19524.
17. Zheng J, Shin OS, Cameron DE, Mekalanos JJ, (2010) Quorum sensing and a global regulator TsrA control expression of type VI secretion and virulence in Vibrio cholerae. Proc Natl Acad Sci U S A 107: 21128-21133.
18. Kitaoka M, Miyata ST, Brooks TM, Unterweger D, Pukatzki S, (2011) VasH is a transcriptional regulator of the type VI secretion system functional in endemic and pandemic Vibrio cholerae. J Bacteriol 193: 6471-6482.
19. Bernard CS, Brunet YR, Gavioli M, Lloubes R, Cascales E, (2011) Regulation of type VI secretion gene clusters by sigma54 and cognate enhancer binding proteins. J Bacteriol 193: 2158-2167.
20. Dong TG, Mekalanos JJ, (2012) Characterization of the RpoN regulon reveals differential regulation of T6SS and new flagellar operons in Vibrio cholerae O37 strain V52. Nucleic Acids Res.
21. Miyata ST, Kitaoka M, Brooks TM, McAuley SB, Pukatzki S, (2011) Vibrio cholerae requires the type VI secretion system virulence factor VasX to kill Dictyostelium discoideum. Infect Immun 79: 2941-2949.
22. Unterweger D, Kitaoka M, Miyata ST, Bachmann V, Brooks TM, et al. (2012) Constitutive type VI secretion system expression gives Vibrio cholerae intra- and interspecific competitive advantages. PLoS One 7: e48320.
23. Hood RD, Singh P, Hsu F, Guvener T, Carl MA, et al. (2010) A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7: 25-37.
24. Mougous JD, Cuff ME, Raunser S, Shen A, Zhou M, et al. (2006) A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312: 1526-1530.
25. Schwarz S, West TE, Boyer F, Chiang WC, Carl MA, et al. (2010) Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog 6 (8):: e1001068.
26. Murdoch SL, Trunk K, English G, Fritsch MJ, Pourkarimi E, et al. (2011) The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors. J Bacteriol 193: 6057-6069.
27. Aubert DF, Flannagan RS, Valvano MA, (2008) A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect Immun 76: 1979-1991.
28. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, et al. (2011) The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun 79: 1512-1525.
29. Burtnick MN, DeShazer D, Nair V, Gherardini FC, Brett PJ, (2010) Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect Immun 78: 88-99.
30. Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, et al. (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol 64: 1466-1485.
31. Wang X, Wang Q, Xiao J, Liu Q, Wu H, et al. (2009) Edwardsiella tarda T6SS component evpP is regulated by esrB and iron, and plays essential roles in the invasion of fish. Fish Shellfish Immunol 27: 469-477.
32. Suarez G, Sierra JC, Sha J, Wang S, Erova TE, et al. (2008) Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila. Microb Pathog 44: 344-361.
33. Basler M, Ho BT, Mekalanos JJ, (2013) Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell 152: 884-894.
34. Ishikawa T, Sabharwal D, Broms J, Milton DL, Sjostedt A, et al. (2012) Pathoadaptive conditional regulation of the type VI secretion system in Vibrio cholerae O1 strains. Infect Immun 80: 575-584.
35. Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, et al. (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475: 343-347.
36. Russell AB, Singh P, Brittnacher M, Bui NK, Hood RD, et al. (2012) A widespread bacterial type VI secretion effector superfamily identified using a heuristic approach. Cell Host Microbe 11: 538-549.
37. Gratia A, (1925) Sur un remarquable exemple d'antagonism entre deux souches de colibacille. Comptes Rendus des Seances et Memoires de la Societe de Biologie 93: 1040-1041.
38. Chak KF, Kuo WS, Lu FM, James R, (1991) Cloning and characterization of the ColE7 plasmid. J Gen Microbiol 137: 91-100.
39. Cooper PC, James R, (1984) Two new E colicins, E8 and E9, produced by a strain of Escherichia coli. J Gen Microbiol 130: 209-215.
40. Schaller K, Nomura M, (1976) Colicin E2 is DNA endonuclease. Proc Natl Acad Sci U S A 73: 3989-3993.
41. Senior BW, Holland IB, (1971) Effect of colicin E3 upon the 30S ribosomal subunit of Escherichia coli. Proc Natl Acad Sci U S A 68: 959-963.
42. Bowman CM, Dahlberg JE, Ikemura T, Konisky J, Nomura M, (1971) Specific inactivation of 16S ribosomal RNA induced by colicin E3 in vivo. Proc Natl Acad Sci U S A 68: 964-968.
43. Bowman CM, Sidikaro J, Nomura M, (1971) Specific inactivation of ribosomes by colicin E3 in vitro and mechanism of immunity in colicinogenic cells. Nat New Biol 234: 133-137.
44. Boon T, (1972) Inactivation of ribosomes in vitro by colicin E 3 and its mechanism of action. Proc Natl Acad Sci U S A 69: 549-552.
45. Schaller K, Holtje JV, Braun V, (1982) Colicin M is an inhibitor of murein biosynthesis. J Bacteriol 152: 994-1000.
46. Elkins P, Bunker A, Cramer WA, Stauffacher CV, (1997) A mechanism for toxin insertion into membranes is suggested by the crystal structure of the channel-forming domain of colicin E1. Structure 5: 443-458.
47. Vetter IR, Parker MW, Tucker AD, Lakey JH, Pattus F, et al. (1998) Crystal structure of a colicin N fragment suggests a model for toxicity. Structure 6: 863-874.
48. Reeves P, (1968) Mode of action of colicins of types E1, E2, E3, and K. J Bacteriol 96: 1700-1703.
49. Luria SE, (1964) On the Mechanisms of Action of Colicins. Ann Inst Pasteur (Paris) 107: SUPPL: 67-73.
50. Zakharov SD, Cramer WA, (2002) Insertion intermediates of pore-forming colicins in membrane two-dimensional space. Biochimie 84: 465-475.
51. Zakharov SD, Kotova EA, Antonenko YN, Cramer WA, (2004) On the role of lipid in colicin pore formation. Biochim Biophys Acta 1666: 239-249.
52. Schein SJ, Kagan BL, Finkelstein A, (1978) Colicin K acts by forming voltage-dependent channels in phospholipid bilayer membranes. Nature 276: 159-163.
53. Fields KL, Luria SE, (1969) Effects of colicins E1 and K on cellular metabolism. J Bacteriol 97: 64-77.
54. Fields KL, Luria SE, (1969) Effects of colicins E1 and K on transport systems. J Bacteriol 97: 57-63.
55. Phillips SK, Cramer WA, (1973) Properties of the fluorescence probe response associated with the transmission mechanism of colicin E1. Biochemistry 12: 1170-1176.
56. Cascales E, Buchanan SK, Duche D, Kleanthous C, Lloubes R, et al. (2007) Colicin biology. Microbiol Mol Biol Rev 71: 158-229.
57. Espesset D, Duche D, Baty D, Geli V, (1996) The channel domain of colicin A is inhibited by its immunity protein through direct interaction in the Escherichia coli inner membrane. EMBO J 15: 2356-2364.
58. Cameron DE, Urbach JM, Mekalanos JJ, (2008) A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae. Proc Natl Acad Sci U S A 105: 8736-8741.
59. Metcalf WW, Jiang W, Daniels LL, Kim SK, Haldimann A, et al. (1996) Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria. Plasmid 35: 1-13.
60. Guzman LM, Belin D, Carson MJ, Beckwith J, (1995) Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177: 4121-4130.
61. White AP, Allen-Vercoe E, Jones BW, DeVinney R, Kay WW, et al. (2007) An efficient system for markerless gene replacement applicable in a wide variety of enterobacterial species. Can J Microbiol 53: 56-62.
62. Hsiao A, Liu Z, Joelsson A, Zhu J, (2006) Vibrio cholerae virulence regulator-coordinated evasion of host immunity. Proc Natl Acad Sci U S A 103: 14542-14547.
63. Miyata ST, Kitaoka M, Wieteska L, Frech C, Chen N, et al. (2010) The Vibrio cholerae type VI secretion system: evaluating its role in the human disease cholera. Front Microbiol 1: 117.
64. Zheng J, Ho B, Mekalanos JJ, (2011) Genetic analysis of anti-amoebae and anti-bacterial activities of the type VI secretion system in Vibrio cholerae. PLoS One 6: e23876.
65. Gode-Potratz CJ, McCarter LL, (2011) Quorum sensing and silencing in Vibrio parahaemolyticus. J Bacteriol 193: 4224-4237.
66. Ma L, Zhang Y, Yan X, Guo L, Wang L, et al. (2012) Expression of the type VI secretion system 1 component Hcp1 is indirectly repressed by OpaR in Vibrio parahaemolyticus. ScientificWorldJournal 2012: 982140.
67. Espesset D, Corda Y, Cunningham K, Benedetti H, Lloubes R, et al. (1994) The colicin A pore-forming domain fused to mitochondrial intermembrane space sorting signals can be functionally inserted into the Escherichia coli plasma membrane by a mechanism that bypasses the Tol proteins. Mol Microbiol 13: 1121-1131.
68. Aoki SK, Pamma R, Hernday AD, Bickham JE, Braaten BA, et al. (2005) Contact-dependent inhibition of growth in Escherichia coli. Science 309: 1245-1248.
69. Rakin A, Boolgakowa E, Heesemann J, (1996) Structural and functional organization of the Yersinia pestis bacteriocin pesticin gene cluster. Microbiology 142 (Pt 12):: 3415-3424.
70. Aoki SK, Webb JS, Braaten BA, Low DA, (2009) Contact-dependent growth inhibition causes reversible metabolic downregulation in Escherichia coli. J Bacteriol 191: 1777-1786.
71. Han KD, Ahn DH, Lee SA, Min YH, Kwon AR, et al. (2013) Identification of chromosomal HP0892-HP0893 toxin-antitoxin proteins in Helicobacter pylori and structural elucidation of their protein-protein interaction. J Biol Chem 288 (8):: 6004-13.
72. Dougan G, Saul M, Warren G, Sherratt D, (1978) A Functional Map of Plasmid ColE1. Molecular and General Genetics 158: 325-327.
73. Andreoli PM, Overbeeke N, Veltkamp E, van Embden JD, Nijkamp HJ, (1978) Genetic map of the bacteriocinogenic plasmid CLO DF13 derived by insertion of the transposon Tn901. Mol Gen Genet 160: 1-11.
74. Ma AT, Mekalanos JJ, (2010) In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci U S A 107: 4365-4370.
75. Miyata ST, Bachmann V, Pukatzki S, (2013) Type VI secretion system regulation as a consequence of evolutionary pressure. Journal of Medical Microbiology 62 (Pt 5):: 663-76.
76. Yang CC, Konisky J, (1984) Colicin V-treated Escherichia coli does not generate membrane potential. J Bacteriol 158: 757-759.
77. Dankert JR, Uratani Y, Grabau C, Cramer WA, Hermodson M, (1982) On a domain structure of colicin E1. A COOH-terminal peptide fragment active in membrane depolarization. J Biol Chem 257: 3857-3863.
78. Uratani Y, Hoshino T, (1984) Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential. J Bacteriol 157: 632-636.
79. Jacob F, Siminovitch L, Wollman E, (1952) Sur la biosynthese d'une colicine et sur son mode d'action. Annales de l'Institut Pasteur (Paris) 83: 295-315.
80. Jakes KS, Model P, (1979) Mechanism of export of colicin E1 and colicin E3. J Bacteriol 138: 770-778.
81. Cavard D, Howard SP, Lloubes R, Lazdunski C, (1989) High-level expression of the colicin A lysis protein. Mol Gen Genet 217: 511-519.
82. Luirink J, de Graaf FK, Oudega B, (1987) Uncoupling of synthesis and release of cloacin DF13 and its immunity protein by Escherichia coli. Mol Gen Genet 206: 126-132.